ALPS Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

ALPS Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,789	Closed	-$340K	–	997
2021 Q3	$340K	Sell	14,789 -1,090	-7%	-$32.4K	﹤0.01%	798
2021 Q2	$697K	Buy	+15,879	New	+$885K	0.01%	473
2020 Q2	–	Sell	-17,247	Closed	-$1.3M	–	840
2020 Q1	$1.3M	Sell	17,247 -1,861	-10%	-$214K	0.02%	246
2019 Q4	$2.63M	Buy	19,108 +192	+1%	+$23.3K	0.02%	205
2019 Q3	$2.25M	Sell	18,916 -939	-5%	-$131K	0.02%	202
2019 Q2	$2.78M	Buy	+19,855	New	+$3.49M	0.02%	196

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

ALPS Advisors's ORTX Position: Q4 2021 in Review

ALPS Advisors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 14,789 shares — an estimated $340K sold.

ALPS Advisors first reported a position in ORTX in Q2 2019 and held it in 6 quarters. The position peaked at $2.78M in Q2 2019. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

ALPS Advisors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
ALPS Advisors sold 14,789 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $340K.
ALPS Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 6 quarters.
ALPS Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $2.78M in Q2 2019.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.